Pharma’s drug discount fight intensifies as state 340B cases reach higher courtsnews2025-09-10T18:47:44+00:00September 10th, 2025|Endpoints News|
API maker Hikal hit with FDA warning letter over alleged metal contaminationnews2025-09-10T15:22:44+00:00September 10th, 2025|Endpoints News|
Abridge takes on prior authorizationnews2025-09-10T15:22:04+00:00September 10th, 2025|Endpoints News|
Avidity shares functional data ahead of plans to submit Duchenne exon skipping drug by year’s endnews2025-09-10T14:59:18+00:00September 10th, 2025|Endpoints News|
PMV to pursue FDA approval in ovarian cancer; Amylyx reveals $175M offeringnews2025-09-10T14:04:01+00:00September 10th, 2025|Endpoints News|
FDA blocks US imports from Sun Pharma’s Halol site over repeated issuesnews2025-09-10T13:59:27+00:00September 10th, 2025|Endpoints News|
Chinese CRISPR company YolTech raises $45M as it plans for first Phase 3 studynews2025-09-10T13:39:50+00:00September 10th, 2025|Endpoints News|
Hims expands into hormone health with men’s testosterone treatmentnews2025-09-10T13:00:01+00:00September 10th, 2025|Endpoints News|
Odyssey gets $213M Series D after backing out of IPOnews2025-09-10T12:00:00+00:00September 10th, 2025|Endpoints News|
Novo Nordisk to cut 9,000 jobs, posts another profit warning as it refocuses on core medsnews2025-09-10T11:15:22+00:00September 10th, 2025|Endpoints News|
